GlassScriptPhysician profile
Maria J Lozano
NPI 1891778809
$994.03
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $277.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $187.52 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $186.22 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $152.50 | 2019-2020 | |
| Ironshore Pharmaceuticals INC. | $85.77 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $78.64 | 2019-2020 | |
| Shire North American Group INC | $70.28 | 2019 | |
| Allergan, INC. | $69.66 | 2019 | |
| Arbor Pharmaceuticals, INC. | $37.32 | 2019-2020 | |
| Neuronetics, INC. | $32.55 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $19.86 | 2019 | |
| Alfasigma USA, INC. | $18.21 | 2020 | |
| Tris Pharma INC | $14.73 | 2019 | |
| Neurocrine Biosciences, INC. | $14.72 | 2020 | |
| Adlon Therapeutics L.P. | $13.08 | 2019 | |
| Avanir Pharmaceuticals, INC. | $11.77 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Validus Pharmaceuticals LLC | $1.20 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Lozano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.